About
Dr. Weena Krutsawad wrote one of the landmark papers in Thai embryo genetics: the 2020 BioMed Research International study reporting the first Asian single-center experience of blastocyst preimplantation genetic diagnosis with HLA matching — used to prevent thalassemia in affected families and enable curative stem-cell transplantation in twelve siblings (source: hospital doctor profile). She now applies that PGT depth at the Excellent IVF Center of Thonburi Bamrungmuang Hospital, where her declared expertise is infertility treatment, PGT and hysteroscopy (medical license MLN 35403).
She graduated with First-Class Honours in medicine from Chulalongkorn University’s Faculty of Medicine, then took the Thai Board Certification in Obstetrics and Gynecology (2011) and the Subspecialty Board in Reproductive Medicine (2013) from the Medical Council of Thailand.
Beyond the clinic she is the center’s most prolific medical writer: her patient-education articles cover PGT-A/PGT-M/PGT-SR genetic screening techniques, PRP for endometrial preparation and ovarian rejuvenation, ERA endometrial receptivity testing, hysteroscopy before embryo transfer, egg freezing, and causes of female infertility. She holds four morning clinic sessions weekly at the center (typically Monday and Tuesday 08:00–14:00, Thursday and Friday 08:00–13:00 on the current weekly roster, which rotates).
Clinical Expertise
- PGT (preimplantation genetic testing) — PGT-A chromosome screening, PGT-M single-gene disease testing and PGT-SR structural rearrangement screening, run on the center’s in-house NGS platform; the HLA-matching PGT study is her signature publication
- IVF/ICSI treatment — full cycle management from stimulation and retrieval through fertilization and embryo transfer
- Hysteroscopy — direct camera assessment of the uterine cavity to diagnose and correct pathology before embryo transfer, which she describes as essential preparation for IVF/ICSI success
- Endometrial preparation — ERA receptivity testing and PRP (platelet-rich plasma) protocols for thin or unresponsive endometrium, plus PRP ovarian rejuvenation for low-reserve patients (low AMH)
- Recurrent implantation failure work-up — her published center articles target the “good embryos, normal chromosomes, still not pregnant” scenario, sequencing cavity, receptivity and endocrine factors
Why Choose Dr. Weena Krutsawad
A researcher of the exact test you may need: few Bangkok fertility physicians can claim authorship of Thailand’s first reported blastocyst PGT-HLA study. For couples carrying a heritable disease — thalassemia is the flagship example in this region — that is directly relevant experience with embryo selection for both disease avoidance and tissue compatibility.
Whole-uterus perspective: her clinical writing links cavity surgery (hysteroscopy), lining assessment (ERA, PRP endometrial rejuvenation) and embryo quality (PGT) into one preparation logic — she treats implantation as a three-factor problem rather than an embryo-only problem.
Subspecialty board since 2013: more than a decade of reproductive-medicine practice after Chulalongkorn first-class honors training, with continued publication in peer-reviewed journals (gestational diabetes screening, 2010; a randomized trial of depo-medroxyprogesterone and AMH after endometrioma surgery, NCT01791413).
Professional Affiliations
Subspecialty-trained in reproductive medicine under the Medical Council of Thailand; affiliated with the national obstetrics-gynecology and fertility medicine societies. Peer-reviewed output spans reproductive genetics, ovarian endocrinology and obstetric screening, including the Hindawi (BioMed Research International) thalassemia PGT study and a prospective randomized controlled trial registered on ClinicalTrials.gov.
Suitable For
- Couples with a known inherited condition: PGT-M/PGT-HLA questions — thalassemia and other single-gene disease in the family — are her published area of first-hand experience
- Patients facing repeated transfer failure: candidates for a structured cavity-and-receptivity work-up (hysteroscopy, ERA, PRP) before another cycle
- Women with low ovarian reserve or low AMH: the center’s PRP ovarian rejuvenation protocol, which she has written up for patients, is assessed in her consultations
- Anyone planning egg freezing or embryo testing: her articles walk through stimulation, retrieval and freezing logistics, making her a natural first consultation for preservation-focused patients